Resveratrol in cardiovascular disease: what is known from current research? (Q37891880)

24 August 2017

1 reference

title

Resveratrol in cardiovascular disease: what is known from current research? (English)

1 reference

24 August 2017

cardiovascular disease

1 reference

Hong Wang

1

1 reference

24 August 2017

Yue-Jin Yang

2

1 reference

24 August 2017

Hai-Yan Qian

3

1 reference

24 August 2017

Qian Zhang

4

1 reference

24 August 2017

Hui Xu

5

1 reference

24 August 2017

Jian-Jun Li

6

1 reference

24 August 2017

1 May 2012

1 reference

24 August 2017

Heart Failure Reviews

1 reference

24 August 2017

17

1 reference

24 August 2017

437-448

1 reference

24 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-011-9260-4

24 August 2017

0 references

cites work

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Oxidative stress and cardiovascular injury: Part II: animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Endogenous adrenomedullin protects against vascular response to injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Provision of cardiovascular protection by ACE inhibitors: a review of recent trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

The red wine hypothesis: from concepts to protective signalling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Protective effects of resveratrol on small intestines against intestinal ischemia-reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol increases vascular oxidative stress resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Effect of genistein against copper-induced lipid peroxidation of human high density lipoproteins (HDL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Pharmacological preconditioning with resveratrol: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Cytokine abnormalities in the etiology of the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Hypertension, obesity, and inflammation: the complex designs of a deadly trio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Mechanisms of resveratrol-induced platelet apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol and red wine, healthy heart and longevity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Cancer stem cells: a novel paradigm for cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Cholesteryl ester transfer protein and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

The dietary antioxidant resveratrol affects redox changes of PPARalpha activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

AMP-activated protein kinase: Role in metabolism and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Shear stress and plaque development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol and ischemic preconditioning in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Autophagy, redox signaling, and ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Expression of an active LKB1 complex in cardiac myocytes results in decreased protein synthesis associated with phenylephrine-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phosphatidylinositol 3-kinase during muscle differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Curcumin synergizes with resveratrol to inhibit colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Clinical trials of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9260-4

Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model

21 January 2018

1 reference

12 December 2020

Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction

1 reference

12 December 2020

Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway

1 reference

12 December 2020

trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism

1 reference

12 December 2020

Estrogen receptors: new players in diabetes mellitus

1 reference

12 December 2020

Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits

1 reference

12 December 2020

Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2

1 reference

12 December 2020

Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood.

1 reference

12 December 2020

Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).

1 reference

12 December 2020

Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells

1 reference

12 December 2020

Hormetic response of resveratrol against cardioprotection

1 reference

12 December 2020

Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP

1 reference

12 December 2020

Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure

1 reference

12 December 2020

Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol

1 reference

12 December 2020

10.1007/S10741-011-9260-4

Identifiers

DOI

1 reference

24 August 2017

1 reference